The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Kelevo 200 µg tablets for dogs and cats

200 µg/tablet Tablet

LIVISTO Int'l, S.L.VPA10425/018/001

Main Information

Trade NameKelevo 200 µg tablets for dogs and cats
Active SubstancesLevothyroxine sodium
Strength200 µg/tablet
Dosage FormTablet
Licence HolderLIVISTO Int'l, S.L.
Licence NumberVPA10425/018/001

Group Information

ATC CodeQH03AA01 levothyroxine sodium
Therapeutic ClassHormone


Licence Issued11/06/2021
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back